| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cifra de Afaceri - Ron | 427.057 | 687.956 | 861.774 | 687.612 | 605.238 | 392.742 | 562.207 | 595.207 | 918.820 | 881.549 |
| Venituri Totale - Ron | 529.419 | 672.164 | 1.213.092 | 964.088 | 1.110.905 | 556.598 | 2.056.982 | 870.254 | 983.601 | 992.681 |
| Cheltuieli Totale - Ron | 517.670 | 661.375 | 1.126.805 | 949.195 | 1.079.219 | 742.947 | 926.513 | 844.568 | 966.486 | 958.697 |
| Profit/Pierdere Brut - Ron | 11.749 | 10.789 | 86.287 | 14.893 | 31.686 | -186.349 | 1.130.469 | 25.686 | 17.115 | 33.984 |
| Profit/Pierdere Net - Ron | 5.100 | 1.543 | 74.298 | 6.681 | 19.283 | -190.248 | 1.114.292 | 17.448 | 7.927 | 7.538 |
| Salariati | 15 | 23 | 18 | 16 | 15 | 12 | 11 | 8 | 8 | 8 |
Verifica rapoartele financiare pentru firma - Sarmexin Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Active Imobilizate | 64.492 | 69.410 | 0 | 4.860 | 4.219 | 0 | 8.520 | 4.260 | 73.093 | 62.409 |
| Active Circulante | 242.175 | 91.668 | 228.145 | 580.795 | 323.191 | 55.555 | 514.902 | 522.424 | 680.936 | 739.975 |
| Stocuri | 173.279 | 53.320 | 17.863 | 214.259 | 42.018 | 14.949 | 447.894 | 500.187 | 567.352 | 655.397 |
| Creante | 67.541 | 37.911 | 209.834 | 171.329 | 189.452 | 39.613 | 47.635 | 21.925 | 81.272 | 81.376 |
| Casa si conturi | 1.355 | 437 | 448 | 195.207 | 91.721 | 993 | 19.373 | 312 | 32.312 | 3.202 |
| Capitaluri Proprii | -21.492 | -19.999 | -908.907 | -904.344 | -869.285 | -1.092.562 | 20.804 | 28.665 | 35.108 | 43.826 |
| Capital Social | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 |
| Datorii | 712.339 | 1.143.062 | 1.135.802 | 1.488.749 | 1.195.445 | 1.148.117 | 508.222 | 498.674 | 718.921 | 758.558 |
| Venituri in Avans | 0 | 0 | 1.250 | 1.250 | 1.250 | 0 | 0 | 0 | 0 | 0 |
| Curs valutar - RON | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| CAEN Principal | "3109 - 3109" | |||||||||
| CAEN An Financiar |
3109
|
|||||||||
Comentarii - Sarmexin Srl